Navigating the IP and regulatory frameworks to put new medicinal products on the market with optimum protection, can best be described as a maze.
In this session, we will discuss how you can create a solid and long market exclusivity for your new medicines.
Bringing a product to the market most often involves having good investor relations, and to keep the competition at bay and get more than return on investment you will need to understand how you best combine strategies for IP protection and regulatory exclusivity.
The key to competitiveness, license revenues and new investments lies in a strong patent portfolio that protects even when market entry is far away. By combining this with various types of regulatory exclusivity when it's time to put the product on the market, you can maximize your protection. We will focus on discussing the critical decisions required, and the timing of such decisions.
Let us guide you through the maze to minimize the risk of losing market share to others.
Speakers:
- Joanna Applequist, AWA, PhD, Partner, European Patent Attorney.
- Marie Gårdmark, RegSmart Life Science, PhD, Regulatory Advisor.
- Louise Jonshammar, AWA, Partner, Attorney at Law
